Cassiopea SpA logo

SKIN - Cassiopea SpA Share Price

CHF40 -1.6  -3.9%

Last Trade - 4:30pm

Mid Cap
Market Cap £373.9m
Enterprise Value £383.0m
Revenue £n/a
Position in Universe 483rd / 1040
Unlock SKIN Revenue
Relative Strength (%)
1m +3.54%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -6.97%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 0.50 25.2
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Cassiopea SpA revenues was not reported. Net loss decreased 8% to EUR11.7M. Lower net loss reflects Research and development costs decrease of 36% to EUR7.9M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -EUR1.26 to -EUR1.17.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


SKIN Revenue Unlock SKIN Revenue

Net Income

SKIN Net Income Unlock SKIN Revenue

Normalised EPS

SKIN Normalised EPS Unlock SKIN Revenue

PE Ratio Range

SKIN PE Ratio Range Unlock SKIN Revenue

Dividend Yield Range

SKIN Dividend Yield Range Unlock SKIN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SKIN EPS Forecasts Unlock SKIN Revenue
Profile Summary

Cassiopea SpA is an Italy-based company engaged in the biotechnology and medical research industry. The Company is a clinical stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products. The Company's current focus is on the topical treatment of acne, androgenic alopecia (''AGA'') and genital warts. Its portfolio comprises four clinical candidates, such as Winlevi, Breezula, CB-06-01 and CB-06-02, for which the Company owns the worldwide rights. These product candidates are based on three chemical entities (''NCE''). They target unmet medical needs and addressable opportunities in the medical dermatology market. The main shareholder of the Company is Cosmo Pharmaceuticals SA.

Last Annual December 31st, 2019
Last Interim December 31st, 2019
Public Since July 1, 2015
No. of Shareholders: n/a
No. of Employees: 12
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange SIX Swiss Exchange
Shares in Issue 10,750,000
Free Float (0.0%)
Eligible for
SKIN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for SKIN
Upcoming Events for SKIN
Frequently Asked Questions for Cassiopea SpA
What is the Cassiopea SpA share price?

As of 4:30pm, shares in Cassiopea SpA are trading at CHF40, giving the company a market capitalisation of £373.9m. This share price information is delayed by 15 minutes.

How has the Cassiopea SpA share price performed this year?

Shares in Cassiopea SpA are currently trading at CHF40 and the price has moved by -1.71% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cassiopea SpA price has moved by 2.27% over the past year.

What are the analyst and broker recommendations for Cassiopea SpA?

Of the analysts with advisory recommendations for Cassiopea SpA, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cassiopea SpA is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Cassiopea SpA next release its financial results?

Cassiopea SpA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Cassiopea SpA dividend yield?

Cassiopea SpA does not currently pay a dividend.

Does Cassiopea SpA pay a dividend?

Cassiopea SpA does not currently pay a dividend.

When does Cassiopea SpA next pay dividends?

Cassiopea SpA does not currently pay a dividend.

How do I buy Cassiopea SpA shares?

To buy shares in Cassiopea SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cassiopea SpA?

Shares in Cassiopea SpA are currently trading at CHF40, giving the company a market capitalisation of £373.9m.

Where are Cassiopea SpA shares listed? Where are Cassiopea SpA shares listed?

Here are the trading details for Cassiopea SpA:

Country of listing: Switzerland
Exchange: SWX
Ticker Symbol: SKIN
What kind of share is Cassiopea SpA?

Based on an overall assessment of its quality, value and momentum, Cassiopea SpA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cassiopea SpA share price forecast 2020?

Shares in Cassiopea SpA are currently priced at CHF40. At that level they are trading at 52.64% discount to the analyst consensus target price of 0.00.

Analysts covering Cassiopea SpA currently have a consensus Earnings Per Share (EPS) forecast of -1.131 for the next financial year.

How can I tell whether the Cassiopea SpA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cassiopea SpA. Over the past six months, the relative strength of its shares against the market has been 17.55%. At the current price of CHF40, shares in Cassiopea SpA are trading at 10.29% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cassiopea SpA PE Ratio?

We were not able to find PE ratio data for Cassiopea SpA.

Who are the key directors of Cassiopea SpA?

Cassiopea SpA's management team is headed by:

Jan de Vries - CHM
Oyvind Bjordal - NID
Pierpaolo Guzzo - NID
Diana Harbort - CEO
Hans Tanner - CFO
Luigi Moro - CSO
Marco Angelo Pasero - COO
Alessandro Mazzetti - OTH
Marco Lecchi - FID
Who are the major shareholders of Cassiopea SpA?

Here are the top five shareholders of Cassiopea SpA based on the size of their shareholding:

Cosmo Shareholder Group Corporation
Percentage owned: 48.95% (5.26m shares)
Herz/Logistable Group Corporation
Percentage owned: 4.49% (482k shares)
AMG Fondsverwaltung AG Investment Advisor
Percentage owned: 3.82% (411k shares)
LLB Swiss Investment AG Investment Advisor
Percentage owned: 3.55% (382k shares)
AMG Substanzwerte Schweiz Mutual Fund
Percentage owned: 3.37% (362k shares)
Similar to SKIN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.